These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
333 related articles for article (PubMed ID: 25422862)
41. Characteristics of the use of 3-MMC and other new psychoactive drugs in Slovenia, and the perceived problems experienced by users. Sande M Int J Drug Policy; 2016 Jan; 27():65-73. PubMed ID: 25908121 [TBL] [Abstract][Full Text] [Related]
42. Prevalence of Rhabdomyolysis in Sympathomimetic Toxicity: a Comparison of Stimulants. O'Connor AD; Padilla-Jones A; Gerkin RD; Levine M J Med Toxicol; 2015 Jun; 11(2):195-200. PubMed ID: 25468315 [TBL] [Abstract][Full Text] [Related]
43. Investigation of drug products received for analysis in the Swedish STRIDA project on new psychoactive substances. Bäckberg M; Jönsson KH; Beck O; Helander A Drug Test Anal; 2018 Feb; 10(2):340-349. PubMed ID: 28600832 [TBL] [Abstract][Full Text] [Related]
44. Characteristics of analytically confirmed illicit substance-using patients in the Emergency Department. Weng TI; Chen LY; Chen JY; Chen PS; Hwa HL; Fang CC J Formos Med Assoc; 2020 Dec; 119(12):1827-1834. PubMed ID: 32037264 [TBL] [Abstract][Full Text] [Related]
45. Analysis of anonymized pooled urine in nine UK cities: variation in classical recreational drug, novel psychoactive substance and anabolic steroid use. Archer JR; Hudson S; Jackson O; Yamamoto T; Lovett C; Lee HM; Rao S; Hunter L; Dargan PI; Wood DM QJM; 2015 Dec; 108(12):929-33. PubMed ID: 25770158 [TBL] [Abstract][Full Text] [Related]
46. Screening of stimulants including designer drugs in urine using a liquid chromatography tandem mass spectrometry system. O'Byrne PM; Kavanagh PV; McNamara SM; Stokes SM J Anal Toxicol; 2013 Mar; 37(2):64-73. PubMed ID: 23316030 [TBL] [Abstract][Full Text] [Related]
47. Clinical experience with and analytical confirmation of "bath salts" and "legal highs" (synthetic cathinones) in the United States. Spiller HA; Ryan ML; Weston RG; Jansen J Clin Toxicol (Phila); 2011 Jul; 49(6):499-505. PubMed ID: 21824061 [TBL] [Abstract][Full Text] [Related]
48. Multiple-drug toxicity caused by the coadministration of 4-methylmethcathinone (mephedrone) and heroin. Dickson AJ; Vorce SP; Levine B; Past MR J Anal Toxicol; 2010 Apr; 34(3):162-8. PubMed ID: 20406541 [TBL] [Abstract][Full Text] [Related]
49. The PMMA epidemic in Norway: comparison of fatal and non-fatal intoxications. Vevelstad M; Øiestad EL; Middelkoop G; Hasvold I; Lilleng P; Delaveris GJ; Eggen T; Mørland J; Arnestad M Forensic Sci Int; 2012 Jun; 219(1-3):151-7. PubMed ID: 22257968 [TBL] [Abstract][Full Text] [Related]
50. Mephedrone toxicity in a Scottish emergency department. Regan L; Mitchelson M; Macdonald C Emerg Med J; 2011 Dec; 28(12):1055-8. PubMed ID: 21183522 [TBL] [Abstract][Full Text] [Related]
51. GC-MS Quantification Method for Mephedrone in Plasma and Urine: Application to Human Pharmacokinetics. Olesti E; Pujadas M; Papaseit E; Pérez-Mañá C; Pozo ÓJ; Farré M; de la Torre R J Anal Toxicol; 2017 Mar; 41(2):100-106. PubMed ID: 27798075 [TBL] [Abstract][Full Text] [Related]
52. Changes in illicit, licit and stimulant designer drug use patterns in South-East Hungary between 2008 and 2015. Árok Z; Csesztregi T; Sija É; Varga T; Kereszty ÉM; Tóth RA; Institóris L Leg Med (Tokyo); 2017 Sep; 28():37-44. PubMed ID: 28759769 [TBL] [Abstract][Full Text] [Related]
53. The detection of mephedrone (4-methylmethcathinone) in 4 fatalities in Scotland. Torrance H; Cooper G Forensic Sci Int; 2010 Oct; 202(1-3):e62-3. PubMed ID: 20685050 [No Abstract] [Full Text] [Related]
54. Fatal intoxication with 3-methyl-N-methylcathinone (3-MMC) and 5-(2-aminopropyl)benzofuran (5-APB). Adamowicz P; Zuba D; Byrska B Forensic Sci Int; 2014 Dec; 245():126-32. PubMed ID: 25447185 [TBL] [Abstract][Full Text] [Related]
55. Toxicological findings in a fatal multidrug intoxication involving mephedrone. Gerace E; Petrarulo M; Bison F; Salomone A; Vincenti M Forensic Sci Int; 2014 Oct; 243():68-73. PubMed ID: 24846124 [TBL] [Abstract][Full Text] [Related]
56. Underestimated impact of novel psychoactive substances: laboratory confirmation of recreational drug toxicity in Oslo, Norway. Vallersnes OM; Persett PS; Øiestad EL; Karinen R; Heyerdahl F; Hovda KE Clin Toxicol (Phila); 2017 Aug; 55(7):636-644. PubMed ID: 28406320 [TBL] [Abstract][Full Text] [Related]
57. Detection and quantification of new psychoactive substances (NPSs) within the evolved "legal high" product, NRG-2, using high performance liquid chromatography-amperometric detection (HPLC-AD). Zuway KY; Smith JP; Foster CW; Kapur N; Banks CE; Sutcliffe OB Analyst; 2015 Sep; 140(18):6283-94. PubMed ID: 26244169 [TBL] [Abstract][Full Text] [Related]
58. An LC-MS/MS methodological approach to the analysis of hair for amphetamine-type-stimulant (ATS) drugs, including selected synthetic cathinones and piperazines. Lendoiro E; Jiménez-Morigosa C; Cruz A; Páramo M; López-Rivadulla M; de Castro A Drug Test Anal; 2017 Jan; 9(1):96-105. PubMed ID: 26914712 [TBL] [Abstract][Full Text] [Related]
59. Cardiotoxicity After Synthetic Cathinone Use; Two Cases, A Case Series and Scoping Review. Groenewegen KL; Gresnigt FMJ; Lonkhuyzen JJN; den Haan C; Franssen EJF; Riezebos RK; Ohana D; de Lange DW Cardiovasc Toxicol; 2024 Mar; 24(3):209-224. PubMed ID: 38411851 [TBL] [Abstract][Full Text] [Related]
60. Drugs for youth via Internet and the example of mephedrone. Vardakou I; Pistos C; Spiliopoulou Ch Toxicol Lett; 2011 Mar; 201(3):191-5. PubMed ID: 21187132 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]